McIlrath & Eck’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-39
Closed -$8.27K 956
2023
Q3
$8.27K Hold
39
﹤0.01% 576
2023
Q2
$7.51K Sell
39
-6
-13% -$1.19K ﹤0.01% 600
2023
Q1
$9.11K Sell
45
-298
-87% -$47.8K ﹤0.01% 571
2022
Q4
$44.1K Hold
343
0.01% 265
2022
Q3
$47K Hold
343
0.01% 254
2022
Q2
$61K Hold
343
0.02% 203
2022
Q1
$49K Buy
343
+9
+3% +$1.22K 0.01% 245
2021
Q4
$52K Hold
334
0.01% 242
2021
Q3
$57K Buy
334
+272
+439% +$42.3K 0.02% 217
2021
Q2
$10K Hold
62
﹤0.01% 529
2021
Q1
$9K Buy
62
+32
+107% +$5.16K ﹤0.01% 500
2020
Q4
$5K Hold
30
﹤0.01% 548
2020
Q3
$6K Buy
+30
New +$5.02K ﹤0.01% 469
2019
Q4
Sell
-234
Closed -$20K 670
2019
Q3
$20K Buy
+234
New +$17.2K 0.01% 219

Other funds holding SGEN

McIlrath & Eck's SGEN Position: Q4 2023 in Review

McIlrath & Eck sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 39 shares — an estimated $8.27K sold.

McIlrath & Eck first reported a position in SGEN in Q3 2019 and held it in 14 quarters. The position peaked at $61K in Q2 2022. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • McIlrath & Eck reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • McIlrath & Eck sold 39 Seagen Inc. Common Stock shares in Q4 2023, an estimated $8.27K.
  • McIlrath & Eck first reported a position in Seagen Inc. Common Stock in Q3 2019 and held it in 14 quarters.
  • McIlrath & Eck's Seagen Inc. Common Stock position peaked at $61K in Q2 2022.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on McIlrath & Eck's 13F filing for Q4 2023, filed 6 Feb 2024.